REQUEST A DEMO
Total
USD $0.00
Search more companies

NPF Transmedteh OOO (НПФ Трансмедтех ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: NPF Transmedteh OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

NPF Transmedteh OOO (НПФ Трансмедтех ООО) is based in Russia, with the head office in Lyubertsy. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on June 26, 2017. There was a net sales revenue drop of 32.22% reported in NPF Transmedteh OOO (НПФ Трансмедтех ООО)’s latest financial highlights for 2024. There was a total negative growth of 3.83% in NPF Transmedteh OOO (НПФ Трансмедтех ООО)’s total assets over the same period. In, 2024, the company’s net profit margin decreased by 17.26%.

Headquarters
3-E Pochtovoe Otdelenie, 57, 2, 1
Lyubertsy; Moscow Oblast; Postal Code: 140008

Contact Details: Purchase the NPF Transmedteh OOO (НПФ Трансмедтех ООО) report to view the information.

Basic Information
Financial Auditors:
Purchase the NPF Transmedteh OOO (НПФ Трансмедтех ООО) report to view the information.
Incorporation Date:
June 26, 2017
Company Performance
Financial values in the chart are available after NPF Transmedteh OOO (НПФ Трансмедтех ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-32.22%
Total operating revenue
-32.22%
Operating profit (EBIT)
-69.41%
Net Profit (Loss) for the Period
-73.19%
Total Assets
-3.83%
Total Equity
9.17%
Operating Profit Margin (ROS)
-16.2%
Net Profit Margin
-17.26%
Return on Equity (ROE)
-121.03%
Debt/Equity
-3.36%
Quick Ratio
19.3%
Cash Ratio
5.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?